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Abstract. Mucoadhesion-based drug delivery systems have recently gained interest because
of their bio-adhesion capability, which results in enhanced residence time leading to prolonged
duration of action with the mucosal surface, potentially improving compliance and convenience.
Mucoadhesion testing of these formulations is widely reported; however, this is technically
challenging due to the absence of any standard methods and difficulty in conducting
mucoadhesion, formulation-mucosal surface interaction, mucosal surface topography and drug
release in a single experiment. As these measurements are currently conducted separately, on
replicate formulations, results can often be subjective and difficult to correlate. Hence, the aim of
the present study was to develop a new AFM-based single-entity ex vivo muco-dissolution
(MUCO-DIS) technique to simultaneously evaluate mucoadhesion force, 3D surface topogra-
phy, polymer dissolution and drug release characteristics. To demonstrate the potential of the
current technique, the interactions between model pectin microparticles containing metformin
HCl and a range of gastrointestinal mucosal surfaces (gastric, small intestine, large intestine and
buccal) were studied. This novel system has not only successfully determined the mucoadhesion
force, polymer dissolution and drug release information but has also highlighted the difference in
microparticle performance with different mucosal targets. The current work has highlighted the
potential of this newly developed MUCO-DIS system and we believe this will be a valuable tool
for characterising these popular pharmaceutical formulations. This technique could also provide
an opportunity to other scientific fields to evaluate materials, substrate behaviour and their
interactions in their hydrated state at nanoscale with real-time chemical and surface mapping.
KEY WORDS: mucoadhesion; Ex vivo; nanoscale; nanodissolution; adhesion force; surface texture; 3D
printing; gastrointestinal mucosa; surface roughness; drug release; matrix erosion; AFM.
INTRODUCTION
Mucoadhesive performance is considered an important
attribute of polymers intended for many drug delivery and tissue
engineering applications, resulting in an extended duration of
contact with the mucosal surface. This has applications for the
delivery of drugs, bioactive peptides and nutritional ingredients
to specific sites in the body (e.g., oral cavity, nose, eye and
vagina) (1). Numerous studies have investigated the
mucoadhesive potential of polymers (2–6). Various theories
have been proposed including: (a) diffusion, (b) adsorption, (c)
wetting, (d) electrostatic and (e) fracture theory (7).
Upon delivery, these formulations tend to hydrate and
interact with the mucosal surface. However, under condi-
tions when the amount of water or biological fluid is
limited, for example in the buccal cavity, rectum, nose and
vagina, these formulations might require time to attain
adequate hydration (8,9). In these circumstances, assess-
ment of the formulation-mucosal interaction, especially the
mucoadhesive force, becomes relevant. However, there is
no standard test method established for mucoadhesion, and
subsequently the data attained can be subjective and
challenging to compare due the different parameters used
as measures of adhesion force. Additionally, results depend
on the experimental conditions, for example applied force,
duration of contact, polymer concentration, pH level and
ionic strength of biological fluids. This can lead to
conflicting conclusions; for example, the work carried out
by Schmidgall and Hensel concluded that LM pectin is
more mucoadhesive than high-methoxy (HM) pectin using
chemical analysis (10). However, Thirawong et al. found
using texture analysis that HM pectin discs were more
mucoadhesive (11). These may both be true depending on
the circumstances involved and the analysis employed.
1 Department of Pharmacy, School of Applied Sciences, University of
Huddersfield, Huddersfield, HD1 3DH, UK.
2 School of Engineering, Robert Gordon University, Aberdeen, AB10
7GJ, UK.
3 EPSRC Future Metrology Hub, School of Computing and Engi-
neering, University of Huddersfield, Huddersfield, HD1 3DH, UK.
4 To whom correspondence should be addressed. (e–mail:
m.ghori@hud.ac.uk; muhammad.ghori@outlook.com)
AAPS PharmSciTech         (2020) 21:142 
DOI: 10.1208/s12249-020-01697-x
1530-9932/20/0000-0001/0 # 2020 The Author(s)
There are many different methods used in practice to
evaluate mucoadhesion that can be broadly classified into
direct and indirect techniques (7). The methods which
evaluate time or force required for formulation detachment
from the mucosal tissue (texture analyser (11), modified
balance (12), tensile stress tester (13) and atomic force
microscopy (AFM) (9,14)), are direct measurement tech-
niques. However, indirect measurement techniques are also
used which monitor the interaction between the polymer and
mucus layer (rheology (15), ellipsometry (16), colloidal gold
staining method (17), falling liquid film method (18,19),
mucin particle method and BIACORE (20)).
AFM is considered a powerful technique which can be
used to study adhesion between two materials and can map
surface texture properties at the nanometre scale, facilitating
analysis of single particles (9,14,22–24). In many cases, it has
been used to examine the amount of material sticking to
surfaces. The colloidal probe approach developed by Ducker
et al. has been widely used to evaluate adhesion forces (21).
This approach involves attaching a particle of the material of
interest, most commonly a sphere, to an AFM cantilever. The
AFM is used in force-displacement mode to quantify the
forces between the colloidal probe and substrate surface.
Although AFM is effective in measuring mucoadhesive
ability, there remains a challenge in developing a technique to
reflect what happens in vivo, in a dynamic capacity within a
liquid system. As the polymer hydrates and swells, drug is
released, and its properties change. Currently, there is no
approach for measuring mucoadhesion that can provide
information on the mucoadhesion forces, polymer dissolution
and drug release dynamically for an individual system in a
single set of experiment. Hence, this research aims to develop
a hydrodynamically characterised novel flow-through cell
(muco-dissolution cell) that could be used with AFM for
dynamic, nanoscale, single-entity, in-liquid ex vivo analysis.
The substrate surface topography was studied before and
after the experiments to determine if there was any deposi-
tion of polymer on the mucosal surface. Mucoadhesive
microparticles of pectin and metformin HCl (a water-soluble
antidiabetic drug) were used as a model formulation.
MATERIALS AND METHODS
Materials
High-methoxy citrus pectin and metformin HCl were
purchased from Sigma-Aldrich Chemical Co., UK, and Tokyo
Chemical Industry Ltd., UK, respectively. Sulphuric acid,
phenol, Span 80, hexane and light liquid paraffin (dynamic
viscosity 25–80 mPa s at 20°C) were purchased from Fisher
Scientific Ltd., UK. All the chemicals were of analytical grade
and used as received without any further modification and/or
purification.
Methods
Preparation of Pectin Microparticles
The pectin-based metformin microparticles were pre-
pared using a water in oil (w/o) emulsion solvent evaporation
technique (25–28). Briefly, 0.75% w/v of metformin HCl was
added to 1.5% w/v aqueous pectin solution and stirred at
50°C until the metformin dissolved. The solution was poured
into 200 mL of light liquid paraffin containing 0.5% v/v/Span
80. The aqueous phase was emulsified into the oily phase by
stirring at 80°C for 2.5 h until the aqueous phase had
evaporated. Microparticles were collected and washed three
times with hexane, filtered, dried for 2 h and stored in
desiccators at room temperature until further investigation.
Characterisation of Microparticles
Drug loading was determined by dissolving 50 mg of
microparticles in 0.2 M phosphate buffer under sonication for
at least 1.5 h until microparticles were fully dissolved and
analysed using UV spectroscopy at a wavelength of 233 nm.
The metformin concentration was determined using a stan-
dard calibration curve (linearity (R2) 0.999, LOQ (limit of
quantification) 2.11 μg/mL and LOD (limit of detection)
0.81 μg/mL). The surface morphology of the microparticles
was studied using scanning electron microscopy (SEM)
(Quanta FEG 250) (29).
Experimental Setup for In-liquid Single-Particle Ex Vivo
Nanoscale Dissolution
The flow-through cell was developed using Solidworks®
(version 25, 2017) and constructed from acrylonitrile butadi-
ene styrene using a MakerBot Replicator™ 2X 3D printer
(New York, USA) (Fig. 1). It was a rectangular shaped design
with inlet and outlet ports intended for liquid loading and
withdrawal, respectively. Both inlet and outlet ports were
connected to a channel (of diameter 3.00 mm and depth
2.50 mm) which connected horizontally to a central sample
compartment (10 mm) equipped with a magnetic wafer to
facilitate the process of sample mounting and removal. The
complete unit was connected to a peristaltic pump using
silicon tubing (5-mm diameter), which had a port for sample
loading and unloading. To understand liquid flow within the
muco-dissolution cell, computational fluid dynamics (CFD)
studies were carried out using ANSYS Fluent Software
(ANSYS software Company, PA, USA). A mathematical
computational approach was developed using three-
dimensional Navier-Stokes equations.
Preparation of GI Tissues and Biological Fluids
Gastrointestinal (GI) mucosae from different parts of the
porcine GI tract (buccal, stomach, small intestine and large
intestinal tissues) were obtained from animals immediately
after slaughter at a local abattoir. The tissues were washed
thoroughly with deionised water to remove any undigested
food and the underlying connective tissues were successively
removed to isolate the mucosal membrane. Membranes were
placed in normal saline solution at 4°C and were used within
4 h. The respective artificial biological media for the
appropriate tissue (simulated gastric fluid, simulated intestinal
fluid, simulated colonic fluid and artificial saliva) are de-
scribed elsewhere (30). Moreover, the simulated fluids were
used with their corresponding tissues and each fluid was
subject to its own HPLC calibration.
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3D Surface Texture Analysis of GI Mucosa
Prior to muco-dissolution experiments, the tissue mucosa
was positioned in the muco-dissolution cell under a steady
stream of the appropriate simulated fluid flowing at 10 mL/
min. After 30 min, surface topographical images of the GI
mucosae were collected using AFM (Dimension Icon by
Bruker, UK) in contact mode. A standard optical lever
method with a small offset of force and low spring constant
(0.07 N/m) bearing probes, MLCT (microlever cantilever tip),
were employed. An auto-relocation algorithm was used to
locate the same area post-dissolution. Quantitative surface
texture parameters of the mucosal tissue before and after
contact with the metformin-loaded pectin microparticles were
determined using MATLAB®2017 software (The
MathWorks, Inc., USA) (31,32).
In-liquid Mucoadhesion Force Measurement
In-liquid mucoadhesive force measurements were deter-
mined using the 3D-printed muco-dissolution flow-through
cell attached to the atomic force microscope (Dimension
Icon®, Bruker Nano Surfaces Ltd., Coventry, UK) in contact
mode (Fig. 2). The experiments were performed at room
temperature (25°C) and 40–50% relative humidity. Micropar-
ticles (40–150 μm) were carefully fixed to the colloidal probes
using epoxy glue (fixation was confirmed using SEM, Fig. 3a).
Before introducing the microparticle into the muco-
dissolution cell, the appropriate biological medium was
flushed through for at least 30 min at a flow rate of 10 mL/
min removing any air bubbles from the tubing. Once a steady
flow was established, the mucoadhesive force was determined
0, 5, 10, 20, 40, 60 and 120 s at fifteen various positions on
tissues, and an average measurement was calculated and used
for further data analysis. This necessitated the use of a
different particle for each force measurement. A typical force
vs. distance curve is illustrated in Fig. 3b. Moreover, to
understand the impact of bio-adhesion on drug release
properties, the same colloidal probe approach was used to
evaluate the dissolution properties of microparticles in the
absence of mucosal surfaces which acts as a control. After
each predetermined time (0, 5, 10, 20, 40, 60 and 120 s), a 250-
μL sample was collected from the sampling port using a
microsyringe and an equal amount of fresh buffer was
introduced. Surface texture analysis of the mucosal tissues
post-experiment was carried out as detailed in the “3D
Surface Texture Analysis of GI Mucosa” section.
Drug Release
Metformin concentrations were determined by HPLC
using a reversed-phase C18 column (Phenomenex Ltd.,
Cheshire, UK) and mobile phase consisting of methanol and
0.05 mol L−1 (NH4)H2PO4 (35:65% v/v). The flow rate of the
mobile phase was maintained at 1.5 mL/min with an injection
volume of 20 μL. A wavelength of 234 nm was used for
metformin detection and LCsolution software was used for
data analysis. A linear relationship was established (R2
0.999), and LOD and LOQ were 0.66 μg/mL and 2.01 μg/
mL, respectively. (33).
Polymer Dissolution and Erosion Analysis
To quantify dissolved pectin, a previously described
procedure was adapted (31,32,34,35). Briefly, 20 μL of 5%
v/v phenol was added to 20 μL of the dissolution medium,
containing any dissolved pectin, in microplate wells followed
by mixing for 5 min using a shaking plate mixer. Concentrated
H2SO4 (100 μL) was added to each well and mixed again for
5 min. The solutions were then incubated for 15 min at room
temperature (20–25°C) before the UV absorbance was read
at 490 nm using a microplate reader and dissolved pectin was
quantified using a standard calibration curve. Additionally,
the overall matrix erosion was calculated by simply summing
the drug and pectin dissolved at each specified time point.
Statistical Analysis
SPSS software version 20 was used for two-way analysis
of variance with post hoc test (p < 0.05).
RESULTS AND DISCUSSION
Drug entrapment efficiency in the microparticles was
74.1 ± 4.2% which is in good agreement with the literature
(25,26). The microparticles were spherical with no obvious
cracks or holes on their surface (Fig. 4); hence, the quality
Fig. 1. CAD (computer-aided design) model of muco-dissolution cell: a, b isometric, c bottom, d top, e side and f cross-
sectional views of the model
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was deemed suitable for the current muco-dissolution
experiment.
Hydrodynamics Studies of Muco-dissolution Cell
Fused deposition modelling (FDM) was successfully used
for the development of the muco-dissolution cell and
computational fluid dynamics studies were used to under-
stand liquid flow and mixing phenomena (ANSYS Fluent
Software, ANSYS software Company, PA, USA). The
numerical model of the apparatus is shown in Fig. 5a. The
particle/sphere of radius 0.5 mm was placed in the central
compartment of the cell and attached with a thin stem probe.
An unstructured tetrahedral mesh was generated within the
flow domain, as shown in Fig. 5b, with a mesh size that had
previously been determined to be suitable for accurate
prediction of the flow features within the apparatus (results
not shown). Three-dimensional Navier-Stokes equations were
numerically solved for the laminar flow of the media. Mass
flow inlet boundary conditions were 1 mL/min, while the
outlet boundary was kept at atmospheric pressure conditions.
The numerical model was considered to be isothermal and a
steady-state solver was employed to run the simulations in an
iterative manner. The density and dynamic viscosity of water
at room temperature were used, i.e. 998.2 kg/m3 and 0.890 cP.
The flow domain was spatially discretised using the Green-
Gauss node–based method, while using second-order upwind
schemes for solving the pressure and momentum terms. A
convergence criterion of 1 × 10−6 was used for mass and
momentum conservation. The resulting flow fields were
captured as shown in Fig. 6a, b. The contours have been
shown on a cross-sectional plane in the z-direction. The flow
is taking place from left to right in the contours. Figure 6a
depicts the local variations in static gauge pressures within the
Fig. 2. Schematic illustration of the experimental setup
Fig. 3. a SEM micrographs showing a microparticle attached a cantilever and b a typical force vs. distance curve
acquired using AFM. The maximum depth of the peak is the force required to detach the AFM probe from the
mucosal surface. This depicted curve is from the small intestinal mucosal (SIM) surface after 60-s holding time
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flow domain. The static pressure within the muco-dissolution
cell was 0.1 Pa. It is evident that the pressure change within
the muco-dissolution cell is gradual, so AFM imaging is
therefore possible. Additionally, Fig. 6b depicts the spatial
variations in the flow velocity magnitude within the flow
domain. A parabolic velocity profile is evident which has
been further plotted in Fig. 6c. The hydrodynamic flow forces
acting on the particle were 0.003 μN, − 0.008 μN and 1 ×
10−6 μN in x-, y- and z-directions, respectively. The existence
of parabolic flow indicates that the particle is under the action
of flow forces. These forces exerted also suggested that the
particle was under the action of a lift force, which is the
primary force acting on it. The drag force acting on the
particle is 64% less than the lift force, while the side force, as
expected in the case of a sphere, is negligibly small compared
with the other two force components. Another point of
interest here is that in both x- and y-directions, the shear
force acting on the particle is significantly higher than the
pressure force. The average wall shear stress acting on the
surface of the particle is 0.0004 Pa, while the maximum wall
shear stress is 0.0017 Pa. Figure 6d depicts the local variations
in the wall shear stress acting on the particle’s surface. It can
be seen that the wall shear stress is maximal on the upper
section of the particle, while it decreases in –ive z-direction,
i.e. towards the base of the muco-dissolution cell. Overall, the
CFD findings confirm a good mixing of liquid around the
point of contact of microparticle.
3D Surface Texture Analysis Before Muco-dissolution
Experiment
3D surface texture analysis was conducted on the
hydrated GI mucosal surfaces (Table I). The measured
parameters relate to the arithmetical mean height (Sa), root
mean square height (Sq), maximum peak height (Sp) and
maximum valley depth (Sv) of the surfaces. As Sa and Sq are
generally used to represent an overall measure of the
roughness of the surface, the initial analysis of the mucosal
surfaces before dissolution revealed the greatest surface
roughness in the gastric mucosa (GM) followed by the small
intestinal mucosa (SIM), large intestinal mucosa (LIM) and
buccal mucosa (BM). Additionally, the Sp and Sv were high
for GM and low for BM. However, although the surface
roughness was greater for SIM than LIM, the height of the
highest peak and the depth of the deepest valley were both
larger for LIM. This may be due to the fact that Sa and Sq are
not able to effectively differentiate valleys, peaks and the
spacing of various surface texture parameters. This was also
evident in the AFM images of the mucosal surfaces prior to
Fig. 4. SEM micrograph of pectin-based metformin microparticle
Fig. 5. a Cross-sectional view of the apparatus and b meshing of the flow domain
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dissolution (Fig. 7a–d). The surface of GM has multiple large
peaks and valleys with no flat surface (Fig. 7a) whereas SIM,
LIM and BM have a flatter surface although numerous
valleys and smaller peaks were still visible (Fig. 7b, c and d,
respectively). This was especially apparent in the AFM image
of the LIM which shows deeper valleys and higher peaks
compared with the SIM and BM (also confirmed by data in
Table I).
Mucoadhesion Force and Work of Detachment Studies
Mucoadhesion force (nN) and work of detachment (FJ)
with respect to holding time (s) are displayed in Fig. 8a and b,
respectively. There was a statistically significant higher
mucoadhesive force and work of detachment for LIM
compared with the other mucosae. The lowest mucoadhesive
force and work of detachment generated from the interaction
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Fig. 6. Variations in a static gauge pressure (in Pa), b flow velocity magnitude (in m/s), c velocity profile in the middle region of the within the
flow domain, c velocity profile in the mid-section of muco-dissolution cell and d wall shear stress on the surface of the particle
Table I. 3D Surface Texture Parameters of GI Mucosal Surfaces Used in This Experiment (n 0 5, Standard Deviations Are in Parenthesis)
Surface texture parameter Microparticle surface Mucosal surface before dissolution
GM SIM LIM BM
Sa (μm) 20.11 (4.55) 123.01 (4.18) 100.2 (5.15) 94.5 (11.12) 77.8 (8.11)
Sq (μm) 24.19 (3.88) 152.6 (6.19) 123.6 (8.12) 131.2 (8.22) 92.7 (4.56)
Sp (μm) 90.44 (5.88) 335.4 (9.11) 289.63 (6.37) 301.3(15.33) 241.3 (6.59)
Sv (μm) 111.26(6.15) 652.8 (10..13) 555.2 (15.29) 591.4 (20.25) 509.6 (15.30)
GM gastric mucosa, SIM small intestinal mucosa, LIM large intestinal mucosa, BM buccal mucosa, GI gastrointestinal, Sa mean height, Sq root
mean square height, Sp maximum peak height, Sv maximum valley depth
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with GM were also statistically significantly lower than for the
other mucosal surfaces. There were statistically insignificant
differences between the SIM and BM at all time points except
for 40 s. This may be due to ionisation of the pectin at higher
pH values of LIM, SIM and BM which causes it to form a
hydrogel, enabling mechanical entanglement. This will in-
crease the contact surface for hydrogen bonding to occur
between the pectin and the mucosal surface (36). There was
an increase in mucoadhesive force and work of detachment as
the holding time was increased (Fig. 8a, b). This was expected
and in agreement with previous findings which attributed this
to an increase in chain entanglement and hydrogen bonding
between the polymer network and mucosa due to increased
hydration and swelling of the pectin surface as contact time is
extended (11,22).
Drug Release, Polymer Dissolution and Matrix Erosion
Studies
Drug release, polymer dissolution and overall matrix
erosion profiles were also obtained from the same formula-
tions (Fig. 9a–c). Polymer located at the outermost surface of
the formulation is in contact with the dissolution media, and
over time the polymeric network starts to dissolve leading to
disentanglement of the polymeric chain. This matrix system
dissolves from the surface. The mechanism and rate of drug
release are controlled by swelling, matrix erosion and/or
diffusion of drug through the gel layer (32,34,37,38). Figure 9
a shows that drug release increases with time for all surfaces.
Any differences in drug release between the different
mucosal surfaces were statistically insignificant until after
Fig. 7. 3D AFM images of a gastric, b small intestinal, c large intestinal and d buccal mucosal surfaces before the muco-
dissolution experiment
Fig. 8. a Mucoadhesion force and b work of detachment as a function by holding time using newly developed muco-
dissolution cell
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60 s. Thereafter, drug release on the LIM was significantly
slower possibly due to hydration and swelling of the pectin
owing to the absence of villi enabling more interaction
between the mucosal surface and the pectin. This is also
why more polymers are dissolved on the LIM compared with
the other mucosal surfaces and may account for the increase
in dissolved polymer from 0- to 20-s holding time. Addition-
ally, as the pKa of the pectin used in this study was 3.5 (39), it
is possible that ionisation of the polymeric chains, higher pHs,
led to greater polymer dissolution than for GM. Figure 9c
displays the overall matrix erosion which is the collective
amount of drug and polymer dissolved (31). There is an
increase in overall matrix erosion as holding time is increased
due to increased hydration and swelling of the polymer.
Furthermore, the drug release, polymer dissolution and
overall matrix erosion in the absence of mucosal surfaces is
displayed in Fig. 10a–c. This data revealed that the drug
release from 60 s onwards was significantly greater in the
simulated intestinal fluid followed by simulated colonic fluid,
artificial saliva and gastric fluid (Fig. 10a). This supports the
current understanding in the literature that metformin
exhibits slower dissolution in lower pH media due to higher
solvation and a larger hydrodynamic radius in the acidic
media caused by additional protonation of metformin (40,41).
Moreover, the ionisation of the polymeric chains at higher pH
values produced similar polymer dissolution profiles as the
profiles containing mucosal surfaces (Fig. 10b). However, the
lack of mucoadhesion due to the absence of a mucosal surface
resulted in insignificant differences in polymer dissolution
between the simulated intestinal fluid and artificial saliva in
the first 20 s. This was in contrast with the polymer dissolution
profiles displayed in Fig. 9b in which polymer dissolution for
LIM was significantly higher than the other mucosal surfaces
due to the initial interaction between the polymer and LIM.
3D Surface Texture Analysis After Muco-dissolution
Experiment
Following dissolution, surface texture parameters for all
mucosal surfaces increased due to interactions between the
pectin and the mucosa (Fig. 11a–d). The differences in surface
texture parameters between SIM, LIM and BM were
statistically insignificant whereas they were significantly lower
in the GM. AFM images of the mucosal surfaces after
dissolution also confirmed this finding (Fig. 12a–d). The
surface of the GM (Fig. 12a) is visibly smoother than the
surfaces of the SIM, LIM and BM (Fig. 12b, c and d,
respectively) and displays multiple ridges rather than large
peaks or valleys. Conversely, the surfaces of the SIM, LIM
and BM clearly display sizeable peaks and valleys, especially
evident for the LIM. It is possible that this increase in surface
roughness may be due to polymer deposition onto the surface
Fig. 9. a Drug release, metformin HCl; b polymer dissolution, pectin; and c overall matrix erosion as a function by holding time by AFM
studies using newly developed muco-dissolution (MUCO-DIS) cell in the presence of mucosal surfaces
Fig. 10. a Drug release, metformin HCl; b polymer dissolution, pectin; and c overall matrix erosion as a function by holding time by AFM
studies using newly developed muco-dissolution (MUCO-DIS) cell in the absence of mucosal surfaces which acts as a control to understand
the impact of bio-adhesion on drug release, polymer dissolution and overall matrix erosion
  142 Page 8 of 11 AAPS PharmSciTech         (2020) 21:142 
of the mucosal membrane following ionisation of the
polymeric chains (42). Moreover, at higher pH values, pectin
is able to form a hydrogel which also contributes to formation
of interchain bridges between the polymer and the mucosal
surface (43,44).
A study conducted by Thirawong et al. investigating the
mucoadhesive properties of various pectins on GI mucosa
also found that adhesion was better when the pH value of the
medium was 4.8 compared with pH 1.2. The authors
concluded that this was due to pectin rapidly converting
from carboxylate anions (pectin salt) to free carboxyl
groups or unionised forms (pectinic acid), as the concen-
tration of hydrogen ions increased at pH 1–2 resulting in
a reduction in the swelling ability of the pectin upon
hydration (11,22).
Differences in the anatomy and structure of the mucosal
surfaces may also be responsible for the increased interac-
tions between the pectin and mucosa. Variations in mucin
content in different regions of the GI tract result in
differences in mucoadhesive properties. Mucin released by
goblet cells in the intestines forms a mucus layer which may
develop a viscous gel covering the epithelia depending on the
pH of the media (11). The presence of larger quantities of
goblet cells in the large intestine also results in greater levels
of mucin on the mucosa of the intestines (5). As discussed
previously, the absence of villi in the LIM allows greater
interactions between the mucosal surface and the pectin,
Fig. 11. Comparison of 3D surface texture parameters of GI mucosal tissues before and after
dissolution experiments
Fig. 12. 3D AFM images of a gastric, b small intestinal, c large intestinal and d buccal mucosal surfaces after the
muco-dissolution experiment
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thereby increasing mucoadhesiveness. It has been reported
that dissociation of carboxyl groups of carbomer and electro-
static repulsion between these groups resulted in the
uncoiling and extension of the molecule at high pH causing
swelling and gel formation of carbomer (34). The enlarge-
ment of the swollen polymer and mucus enhanced the
interdiffusion process and caused mechanical entanglement
and an increase in surface contact for hydrogen bonding and/
or electrostatic interactions between the polymer and the
mucosal network.
CONCLUSIONS AND FUTURE PROSPECTS
This study has demonstrated the successful development
of a new in-liquid single-particle ex vivo nanoscale dissolution
technique for mucoadhesive force, 3D surface topography,
polymer dissolution, drug release and erosion analysis in a
single experiment, negating the need for separate investiga-
tions. The CFD findings confirm a good mixing of liquid
around the point of contact of microparticle. Furthermore,
the present study demonstrated that the current system has a
potential to be used for multiple GI target sites where
mucoadhesion is playing a vital role in controlling the drug
release. It is anticipated that this synchronised approach will
provide researchers an opportunity to explore other polymers
and newly developed mucoadhesive formulations in an
environment that better reflects in vivo situation. Addition-
ally, CFD findings revealed that this system can be adapted
for use for other industrially relevant materials and substrates
to understand their behaviour and interaction in hydrated
state at a nanometric scale with chemical and surface
mapping.
AUTHOR CONTRIBUTIONS
Project concept and design: MUG
Methodology: MUG, PT, BRC
Acquisition of data: JSN, ZR, SM, TA, YC, MUG
Data analysis and interpretation: JSN, TA PT, BRC,
MUG
Writing (first draft): MUG
Writing (review and editing): JSN, ZR, SM, TA, YC, PT,
BRC, MUG
Project administration: MUG
FUNDING INFORMATION
The authors acknowledge the financial support provided
by the University of Huddersfield, Huddersfield, UK.
COMPLIANCE WITH ETHICAL STANDARDS
Competing Interests The authors declare that they have no
conflict of interest.
Open Access This article is licensed under a Creative
Commons Attribution 4.0 International License, which per-
mits use, sharing, adaptation, distribution and reproduction in
any medium or format, as long as you give appropriate credit
to the original author(s) and the source, provide a link to the
Creative Commons licence, and indicate if changes were
made. The images or other third party material in this article
are included in the article's Creative Commons licence, unless
indicated otherwise in a credit line to the material. If material
is not included in the article's Creative Commons licence and
your intended use is not permitted by statutory regulation or
exceeds the permitted use, you will need to obtain permission
directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/.
REFERENCES
1. Grabovac V, Guggi D, Bernkop-Schnürch A. Comparison of the
mucoadhesive properties of various polymers. Adv Drug Deliv
Rev. 2005;57(11):1713–23.
2. Ludwig A. The use of mucoadhesive polymers in ocular drug
delivery. Adv Drug Deliv Rev. 2005;57(11):1595–639.
3. Ugwoke MI, Agu RU, Verbeke N, Kinget R. Nasal
mucoadhesive drug delivery: background, applications, trends
and fu ture per spec t i ves . Adv Drug Del iv Rev.
2005;57(11):1640–65.
4. Salamat-Miller N, Chittchang M, Johnston TP. The use of
mucoadhesive polymers in buccal drug delivery. Adv Drug
Deliv Rev. 2005;57(11):1666–91.
5. Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric
platforms for controlled drug delivery. Eur J Pharm Biopharm.
2009;71(3):505–18.
6. Valenta C. The use of mucoadhesive polymers in vaginal
delivery. Adv Drug Deliv Rev. 2005;57(11):1692–712.
7. Woertz C, Preis M, Breitkreutz J, Kleinebudde P. Assessment of
test methods evaluating mucoadhesive polymers and dosage
forms: an overview. Eur J Pharm Biopharm. 2013;85(3):843–53.
8. Surapaneni MS, Das SK, Das NG. Effect of excipient and
processing variables on adhesive properties and release profile
of pentoxifylline from mucoadhesive tablets. Drug Dev Ind
Pharm. 2006;32(3):377–87.
9. Joergensen L, Klösgen B, Simonsen AC, Borch J, Hagesaether
E. New insights into the mucoadhesion of pectins by AFM
roughness parameters in combination with SPR. Int J Pham.
2011;411(1–2):162–8.
10. Schmidgall J, Hensel A. Bioadhesive properties of
polygalacturonides against colonic epithelial membranes. Int J
Biol Macromol. 2002;30(5):217–25.
11. Thirawong N, Nunthanid J, Puttipipatkhachorn S, Sriamornsak
P. Mucoadhesive properties of various pectins on gastrointesti-
nal mucosa: an in vitro evaluation using texture analyzer. Eur J
Pharm Biopharm. 2007;67(1):132–40.
12. Kast CE, Bernkop-Schnürch A. Thiolated polymers—thiomers:
development and in vitro evaluation of chitosan–thioglycolic
acid conjugates. Biomaterials. 2001;22(17):2345–52.
13. Remunan-Lopez C, Portero A, Vila-Jato JL, Alonso MJ. Design
and evaluation of chitosan/ethylcellulose mucoadhesive
bilayered devices for buccal drug delivery. J Control Release.
1998;55(2–3):143–52.
14. Iijima M, Yoshimura M, Tsuchiya T, Tsukada M, Ichikawa H,
Fukumori Y, et al. Direct measurement of interactions between
stimulation-responsive drug delivery vehicles and artificial
mucin layers by colloid probe atomic force microscopy. Lang-
muir. 2008;24(8):3987–92.
15. Hassan EE, Gallo JM. A simple rheological method for the
in vitro assessment of mucin-polymer bioadhesive bond
strength. Pharm Res. 1990;7(5):491–5.
16. Ivarsson D, Wahlgren M. Comparison of in vitro methods of
measuring mucoadhesion: ellipsometry, tensile strength and
rheological measurements. Colloids Surf B. 2012;92:353–9.
17. Park K. A new approach to study mucoadhesion: colloidal gold
staining. Int J Pharm. 1989;53(3):209–17.
  142 Page 10 of 11 AAPS PharmSciTech         (2020) 21:142 
18. Teng CLC, Ho NFH. Mechanistic studies in the simultaneous
flow and adsorption of polymer-coated latex particles on
intestinal mucus I: methods and physical model development.
J Control Release. 1987;6(1):133–49.
19. Hasçiçek C, Gönül N, Erk N. Mucoadhesive microspheres
containing gentamicin sulfate for nasal administration: prepara-
tion and in vitro characterization. Il Farmaco. 2003;58(1):11–6.
20. Takeuchi H, Thongborisute J, Matsui Y, Sugihara H, Yamamoto
H, Kawashima Y. Novel mucoadhesion tests for polymers and
polymer-coated particles to design optimal mucoadhesive drug
delivery systems. Adv Drug Deliv Rev. 2005;57(11):1583–94.
21. Ducker WA, Senden TJ, Pashley RM. Direct measurement of
colloidal forces using an atomic force microscope. Nature.
1991;353(6341):239–41.
22. Sriamornsak P, Wattanakorn N, Takeuchi H. Study on the
mucoadhesion mechanism of pectin by atomic force microscopy
and mucin-particle method. Carbohydr Polym. 2010;79(1):54–9.
23. Brako F, Thorogate R, Mahalingam S, Raimi-Abraham B, Craig
DQ, Edirisinghe M. Mucoadhesion of progesterone-loaded drug
delivery nanofiber constructs. ACS Appl Mater Interfaces.
2018;10(16):13381–9.
24. Ding D, Kundukad B, Somasundar A, Vijayan S, Khan SA, Doyle
PS. Design of mucoadhesive PLGAmicroparticles for ocular drug
delivery. ACS Appl Mater Interfaces. 2018;1(3):561–71.
25. Banerjee P, Deb J, Roy A, Ghosh A, Chakraborty P. Fabrica-
tion and development of pectin microsphere of metformin
hydrochloride. ISRN Pharmaceutics, 2012.
26. Cetin M, Sahin S. Microparticulate and nanoparticulate drug
delivery systems for metformin hydrochloride. Drug Delivery.
2016;23(8):2796–805.
27. Mukhopadhyay HK, Das S, Bhowmik M, Ray S, Rajabalaya R,
Ghosh L, et al. Preparation and characterization of
polymethacrylate-based matrix microspheres of carbamazepine
using solvent evaporation method. Farmacia. 2014;62(1):137–58.
28. Das SK, Yuvaraja K, Khanam J, Nanda A. Formulation
development and statistical optimization of ibuprofen-loaded
polymethacrylate microspheres using response surface method-
ology. Chem Eng Res Des. 2015;96:1–14.
29. Shahzad Y, Saeed S, Ghori MU, Mahmood T, Yousaf AM,
Jamshaid M, et al. Influence of polymer ratio and surfactants on
controlled drug release from cellulosic microsponges. Int J Biol
Macromol. 2018;109:963–70.
30. Marques MR, Loebenberg R, Almukainzi M. Simulated biolog-
ical fluids with possible application in dissolution testing.
Dissolution Technol. 2011;18(3):15–28.
31. Khizer Z, Akram MR, Sarfraz RM, Nirwan JS, Farhaj S, Yousaf
M, et al. Plasticiser-free 3D printed hydrophilic matrices:
quantitative 3D surface texture, mechanical, swelling, erosion,
drug release and pharmacokinetic studies. Polymers.
2019;11(7):1095.
32. Nirwan JS, Conway BR, Ghori MU. In situ 3D nanoscale
advanced imaging algorithms with integrated chemical imaging
for the characterisation of pharmaceuticals. RSC Adv.
2019;9(28):16119–29.
33. Stepensky D, Friedman SW, Raz I, Hoffman A. Preclinical
evaluation of pharmacokinetic–pharmacodynamic rationale for
oral CR metformin formulation. J Control Release.
2001;71(1):107–15.
34. Ghori MU, Ginting G, Smith AM, Conway BR. Simultaneous
quantification of drug release and erosion from hypromellose
hydrophilic matrices. Int J Pharm. 2014;465(1–2):405–12.
35. Ghori MU. Release kinetics, compaction and electrostatic
properties of hydrophilic matrices 2014; Doctoral dissertation,
University of Huddersfield.
36. Gu JM, Robinson JR, Leung SH. Binding of acrylic polymers to
mucin/epithelial surfaces: structure-property relationships. Crit
Rev Ther Drug Carrier Syst. 1988;5:21–67.
37. Ghori MU, Conway BR. Hydrophilic matrices for oral control
drug delivery. Am J Pharmacol Sci. 2015;3(5):103–9.
38. Ghori MU, Conway BR. Powder compaction: compression
properties of cellulose ethers. Br J Pharm. 2016;1(1).
39. Opanasopit P, Apirakaramwong A, Ngawhirunpat T,
Rojanarata T, Ruktanonchai U. Development and characteri-
zation of pectinate micro/nanoparticles for gene delivery. AAPS
PharmSciTech. 2008;9(1):67–74.
40. Desai D, Wong B, Huang Y, Tang D, Hemenway J, Paruchuri S,
et al. Influence of dissolution media pH and USP1 basket speed
on erosion and disintegration characteristics of immediate
release metformin hydrochloride tablets. Pharm Dev Technol.
2015;20:540–5.
41. Desai D, Wong B, Huang Y, Ye Q, Tang D, Guo H, et al.
Surfactant-mediated dissolution of metformin hydrochloride
tablets: wetting effects versus ion pairs diffusivity. J Pharm Sci.
2014;103:920–6.
42. Sila DN, Van Buggenhout S, Duvetter T, Fraeye I, De Roeck A,
Van Loey A, et al. Pectins in processed fruits and vegetables:
part II—structure–function relationships. Compr Rev Food Sci
Food Saf. 2009;8:86–104.
43. Chatterjee B, Amalina N, Sengupta P, Mandal UK.
Mucoadhesive polymers and their mode of action: a recent
update. J Appl Pharm Sci. 2017;7:195–203.
44. Ghori MU, Mohammad MA, Rudrangi SRS, Fleming LT,
Merchant HA, Smith AM, et al. Impact of purification on
physicochemical, surface and functional properties of okra
biopolymer. Food Hydrocoll. 2017;71:311–20.
Publisher’s Note Springer Nature remains neutral with regard
to jurisdictional claims in published maps and institutional
affiliations.
  142 Page 11 of 11AAPS PharmSciTech         (2020) 21:142 
